Werkgroep Cardiologische centra Nederland

ReVeRA-201 (Completed)

Multi-Centre, Placebo-Controlled, Phase 2 Study of Etripamil Nasal Spray for the Reduction of Ventricular Rate in Patients with Atrial Fibrillation
Medicine
Etripamil
Population
Arrhythmia
Phase
II
Starting year
2022

Director of Study

dr. M.E.W. Hemels (Cardioloog)
Arnhem, Rijnstate Ziekenhuis